Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9540511 | 1.00 | SLC6A2 (0.49) | SLC6A2SLC6A4SLC6A3FFAR1P2RX7 | |
| SCHEMBL7549866 | 1.00 | SLC6A2 (0.49) | SLC6A2SLC6A4SLC6A3FFAR1P2RX7 | |
| SCHEMBL435358 | 0.86 | FFAR1 (0.48) | FFAR1MAPTRAB9A | |
| SCHEMBL13715262 | 0.86 | FFAR1 (0.48) | FFAR1MAPTRAB9A | |
| SCHEMBL13715266 | 0.86 | FFAR1 (0.48) | FFAR1MAPTRAB9A | |
| SCHEMBL14091031 | 0.85 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3RAB9A | |
| SCHEMBL21688300 | 0.84 | FFAR1 (0.56) | FFAR1HPGDSMN1; SMN2RAB9A | |
| SCHEMBL13591240 | 0.82 | ALDH1A1 (0.51) | L3MBTL1GAAHPGDSMN1; SMN2MAPT | |
| SCHEMBL9540445 | 0.81 | FFAR1 (0.43) | FFAR1GAA | |
| SCHEMBL6915959 | 0.81 | FFAR1 (0.69) | SLC6A2SLC6A4SLC6A3FFAR1P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020032351-A1 | Process for the preparation of chiral isofluoroenes | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020032351-A1 | Process for the preparation of chiral isofluoroenes | CYP51A1, CYP4F11, CYP2F1 | SLC6A2 4538/4885SLC6A4 4522/4885SLC6A3 4658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.